Other Species / Isoforms
  CAPN2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K7-ac
_MAGIAAkLAKDREA
Upstream
0 2
Treatment
  • vorinostat
CAPN2 (human) _MAGIAAkLAKDREA K7-ac
CAPN2 iso2 (human) gap -
CAPN2 (mouse) _MAGIAIKLAKDREA K7
CAPN2 (rat) _MAGIAMkLAKDREA K7-ac
S20-p
EAAEGLGsHDrAIkY
0 1
CAPN2 (human) EAAEGLGsHDrAIkY S20-p
CAPN2 iso2 (human) gap -
CAPN2 (mouse) EAAEGLGSHERAIKY S20
CAPN2 (rat) EAAEGLGSHERAIKY S20
R23-m1
EGLGsHDrAIkYLNQ
0 2
CAPN2 (human) EGLGsHDrAIkYLNQ R23-m1
CAPN2 iso2 (human) gap -
CAPN2 (mouse) EGLGSHERAIKYLNQ R23
CAPN2 (rat) EGLGSHERAIKYLNQ R23
K26-ub
GsHDrAIkYLNQDyE
0 2
CAPN2 (human) GsHDrAIkYLNQDyE K26-ub
CAPN2 iso2 (human) gap -
CAPN2 (mouse) GSHERAIKYLNQDYE K26
CAPN2 (rat) GSHERAIKYLNQDYE K26
Y32-p
IkYLNQDyEALRNEC
0 2
CAPN2 (human) IkYLNQDyEALRNEC Y32-p
CAPN2 iso2 (human) gap -
CAPN2 (mouse) IKYLNQDYETLRNEC Y32
CAPN2 (rat) IKYLNQDYETLRNEC Y32
S50-p
GTLFQDPsFPAIPSA
Upstream
Downstream
3 1
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • cell adhesion, altered
  • cell motility, altered
Kinase, in vitro:
  • ERK1 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Treatment
  • 5-HT
  • endothelin
  • fostriecin
  • H2O2
  • IL-6
  • PD98059
  • PDGF
CAPN2 (human) GTLFQDPsFPAIPSA S50-p
CAPN2 iso2 (human) gap -
CAPN2 (mouse) GALFQDPsFPALPSS S50-p
CAPN2 (rat) GALFQDPSFPALPSS S50
K61-ac
IPSALGFkELGPYSs
0 4
CAPN2 (human) IPSALGFkELGPYSs K61-ac
CAPN2 iso2 (human) gap -
CAPN2 (mouse) LPSSLGYKELGPYSS K61
CAPN2 (rat) LPSSLGFKELGPYSS K61
K61-ub
IPSALGFkELGPYSs
0 1
CAPN2 (human) IPSALGFkELGPYSs K61-ub
CAPN2 iso2 (human) gap -
CAPN2 (mouse) LPSSLGYKELGPYSS K61
CAPN2 (rat) LPSSLGFKELGPYSS K61
S68-p
kELGPYSskTRGIEW
0 1
CAPN2 (human) kELGPYSskTRGIEW S68-p
CAPN2 iso2 (human) gap -
CAPN2 (mouse) KELGPYSSKTRGIEW S68
CAPN2 (rat) KELGPYSSKTRGIEW S68
K69-ub
ELGPYSskTRGIEWK
0 2
CAPN2 (human) ELGPYSskTRGIEWK K69-ub
CAPN2 iso2 (human) gap -
CAPN2 (mouse) ELGPYSSKTRGIEWK K69
CAPN2 (rat) ELGPYSSKTRGIEWK K69
K219-ub
AEWYELKkPPPNLFK
0 1
CAPN2 (human) AEWYELKkPPPNLFK K219-ub
CAPN2 iso2 (human) AEWYELKKPPPNLFK K141
CAPN2 (mouse) AEWYELRKPPPNLFK K219
CAPN2 (rat) AEWYELRKPPPNLFK K219
K230-ub
NLFKIIQkALQkGSL
0 1
CAPN2 (human) NLFKIIQkALQkGSL K230-ub
CAPN2 iso2 (human) NLFKIIQKALQKGSL K152
CAPN2 (mouse) NLFKIIQKALEKGSL K230
CAPN2 (rat) NLFKIIQKALEKGSL K230
K234-ub
IIQkALQkGSLLGCS
0 1
CAPN2 (human) IIQkALQkGSLLGCS K234-ub
CAPN2 iso2 (human) IIQKALQKGSLLGCS K156
CAPN2 (mouse) IIQKALEKGSLLGCS K234
CAPN2 (rat) IIQKALEKGSLLGCS K234
K257-ub
SEAITFQkLVkGHAY
0 1
CAPN2 (human) SEAITFQkLVkGHAY K257-ub
CAPN2 iso2 (human) SEAITFQKLVKGHAY K179
CAPN2 (mouse) SEAVTYQKLVkGHAY K257
CAPN2 (rat) SEAVTYQKLVKGHAY K257
K260-ub
ITFQkLVkGHAYSVT
0 4
CAPN2 (human) ITFQkLVkGHAYSVT K260-ub
CAPN2 iso2 (human) ITFQKLVKGHAYSVT K182
CAPN2 (mouse) VTYQKLVkGHAYSVT K260-ub
CAPN2 (rat) VTYQKLVKGHAYSVT K260
K280
ESNGSLQKLIRIRNP
0 1
CAPN2 (human) ESNGSLQKLIRIRNP K280
CAPN2 iso2 (human) ESNGSLQKLIRIRNP K202
CAPN2 (mouse) ESSGSLQKLIRIRNP K280
CAPN2 (rat) ESSGSLQkLIRIRNP K280-ac
K280-ub
ESNGSLQkLIRIRNP
0 2
CAPN2 (human) ESNGSLQkLIRIRNP K280-ub
CAPN2 iso2 (human) ESNGSLQKLIRIRNP K202
CAPN2 (mouse) ESSGSLQkLIRIRNP K280-ub
CAPN2 (rat) ESSGSLQKLIRIRNP K280
Y353-p
DTLTSDTykkWKLTk
0 1
CAPN2 (human) DTLTSDTykkWKLTk Y353-p
CAPN2 iso2 (human) DTLTSDTYKKWKLTK Y275
CAPN2 (mouse) DTLTCDSYkkWKLTK Y353
CAPN2 (rat) DTLTCDSYKKWKLTK Y353
K354-ac
TLTSDTykkWKLTkM
0 20
CAPN2 (human) TLTSDTykkWKLTkM K354-ac
CAPN2 iso2 (human) TLTSDTYKKWKLTKM K276
CAPN2 (mouse) TLTCDSYkkWKLTKM K354-ac
CAPN2 (rat) TLTCDSYKKWKLTKM K354
K355-ac
LTSDTykkWKLTkMD
0 5
CAPN2 (human) LTSDTykkWKLTkMD K355-ac
CAPN2 iso2 (human) LTSDTYKKWKLTKMD K277
CAPN2 (mouse) LTCDSYkkWKLTKMD K355-ac
CAPN2 (rat) LTCDSYKKWKLTKMD K355
K360-ub
ykkWKLTkMDGNWRR
0 2
CAPN2 (human) ykkWKLTkMDGNWRR K360-ub
CAPN2 iso2 (human) YKKWKLTKMDGNWRR K282
CAPN2 (mouse) YkkWKLTKMDGNWRR K360
CAPN2 (rat) YKKWKLTKMDGNWRR K360
S369-p
DGNWRRGstAGGCRN
Upstream
Downstream
2 3
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • cell motility, altered
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • 5-HT
  • 8-Rp-cAMP
  • cAMP_analog
  • endothelin
  • fostriecin
  • H-89
  • H2O2
  • IL-6
  • PD98059
  • PDGF
CAPN2 (human) DGNWRRGstAGGCRN S369-p
CAPN2 iso2 (human) DGNWRRGSTAGGCRN S291
CAPN2 (mouse) DGNWRRGstAGGCRN S369-p
CAPN2 (rat) DGNWRRGSTAGGCRN S369
T370-p
GNWRRGstAGGCRNY
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • cell motility, altered
Kinase, in vitro:
  • PKACA (human)
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • 8-Rp-cAMP
  • cAMP_analog
  • H-89
CAPN2 (human) GNWRRGstAGGCRNY T370-p
CAPN2 iso2 (human) GNWRRGSTAGGCRNY T292
CAPN2 (mouse) GNWRRGstAGGCRNy T370-p
CAPN2 (rat) GNWRRGSTAGGCRNY T370
Y377
tAGGCRNYPNTFWMN
0 1
CAPN2 (human) tAGGCRNYPNTFWMN Y377
CAPN2 iso2 (human) TAGGCRNYPNTFWMN Y299
CAPN2 (mouse) tAGGCRNyPNTFWMN Y377-p
CAPN2 (rat) TAGGCRNYPNTFWMN Y377
K390-sm
MNPQYLIkLEEEDED
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • cell motility, induced
Regulatory protein:
  • SENP3 (human)
  • SENP5 (human)
CAPN2 (human) MNPQYLIkLEEEDED K390-sm
CAPN2 iso2 (human) MNPQYLIKLEEEDED K312
CAPN2 (mouse) MNPQYLIKLEEEDED K390
CAPN2 (rat) MNPQYLIKLEEEDED K390
S403-p
EDEEDGEsGCTFLVG
0 1
CAPN2 (human) EDEEDGEsGCTFLVG S403-p
CAPN2 iso2 (human) EDEEDGESGCTFLVG S325
CAPN2 (mouse) EDEEDGERGCTFLVG R403
CAPN2 (rat) EDDEDGERGCTFLVG R403
K414-ub
FLVGLIQkHRRRQRK
0 1
CAPN2 (human) FLVGLIQkHRRRQRK K414-ub
CAPN2 iso2 (human) FLVGLIQKHRRRQRK K336
CAPN2 (mouse) FLVGLIQKHRRRQRK K414
CAPN2 (rat) FLVGLIQKHRRRQRK K414
S462-p
TNRARERsDtFINLR
0 3
CAPN2 (human) TNRARERsDtFINLR S462-p
CAPN2 iso2 (human) TNRARERSDTFINLR S384
CAPN2 (mouse) TTRARERSDTFINLR S462
CAPN2 (rat) TTRARERSDTFINLR S462
T464-p
RARERsDtFINLREV
0 5
CAPN2 (human) RARERsDtFINLREV T464-p
CAPN2 iso2 (human) RARERSDTFINLREV T386
CAPN2 (mouse) RARERSDTFINLREV T464
CAPN2 (rat) RARERSDTFINLREV T464
K476-ub
REVLNRFkLPPGEYI
0 1
CAPN2 (human) REVLNRFkLPPGEYI K476-ub
CAPN2 iso2 (human) REVLNRFKLPPGEYI K398
CAPN2 (mouse) REVLNRFKLPPGEYV K476
CAPN2 (rat) REVLNRFKLPPGEYV K476
K568-ub
LAKRQDIksDGFSIE
0 1
CAPN2 (human) LAKRQDIksDGFSIE K568-ub
CAPN2 iso2 (human) LAKRQDIKSDGFSIE K490
CAPN2 (mouse) LAKRQDIKSDGFSIE K568
CAPN2 (rat) LAKREDIKSDGFSIE K568
S569-p
AKRQDIksDGFSIET
0 1
CAPN2 (human) AKRQDIksDGFSIET S569-p
CAPN2 iso2 (human) AKRQDIKSDGFSIET S491
CAPN2 (mouse) AKRQDIKSDGFSIET S569
CAPN2 (rat) AKREDIKSDGFSIET S569
S586-p
IMVDMLDsDGsGkLG
0 2
CAPN2 (human) IMVDMLDsDGsGkLG S586-p
CAPN2 iso2 (human) IMVDMLDSDGSGKLG S508
CAPN2 (mouse) IMVDMLDEDGSGKLG E586
CAPN2 (rat) IMVDMLDEDGSGKLG E586
S589-p
DMLDsDGsGkLGLKE
0 3
CAPN2 (human) DMLDsDGsGkLGLKE S589-p
CAPN2 iso2 (human) DMLDSDGSGKLGLKE S511
CAPN2 (mouse) DMLDEDGSGKLGLKE S589
CAPN2 (rat) DMLDEDGSGKLGLKE S589
K591-ub
LDsDGsGkLGLKEFY
0 1
CAPN2 (human) LDsDGsGkLGLKEFY K591-ub
CAPN2 iso2 (human) LDSDGSGKLGLKEFY K513
CAPN2 (mouse) LDEDGSGKLGLKEFY K591
CAPN2 (rat) LDEDGSGKLGLKEFY K591
K609
TKIQKYQKIyREIDV
0 1
CAPN2 (human) TKIQKYQKIyREIDV K609
CAPN2 iso2 (human) TKIQKYQKIYREIDV K531
CAPN2 (mouse) TKIQKYQKIYREIDV K609
CAPN2 (rat) TKIQKYQkIYREIDV K609-ac
Y611-p
IQKYQKIyREIDVDR
0 1
CAPN2 (human) IQKYQKIyREIDVDR Y611-p
CAPN2 iso2 (human) IQKYQKIYREIDVDR Y533
CAPN2 (mouse) IQKYQKIYREIDVDR Y611
CAPN2 (rat) IQKYQkIYREIDVDR Y611
T621-p
IDVDRSGtMNSyEMR
0 1
CAPN2 (human) IDVDRSGtMNSyEMR T621-p
CAPN2 iso2 (human) IDVDRSGTMNSYEMR T543
CAPN2 (mouse) IDVDRSGTMNSYEMR T621
CAPN2 (rat) IDVDRSGTMNSYEMR T621
Y625-p
RSGtMNSyEMRkALE
Upstream
Downstream
1 1
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, inhibited
Putative in vivo kinases:
  • Src (human)
Treatment
  • dasatinib
CAPN2 (human) RSGtMNSyEMRkALE Y625-p
CAPN2 iso2 (human) RSGTMNSYEMRKALE Y547
CAPN2 (mouse) RSGTMNSYEMRKALE Y625
CAPN2 (rat) RSGTMNSYEMRKALE Y625
K629-ub
MNSyEMRkALEEAGF
0 1
CAPN2 (human) MNSyEMRkALEEAGF K629-ub
CAPN2 iso2 (human) MNSYEMRKALEEAGF K551
CAPN2 (mouse) MNSYEMRKALEEAGF K629
CAPN2 (rat) MNSYEMRKALEEAGF K629
K674-ub
VRLETLFkIFKQLDP
0 4
CAPN2 (human) VRLETLFkIFKQLDP K674-ub
CAPN2 iso2 (human) VRLETLFKIFKQLDP K596
CAPN2 (mouse) VRLETLFkIFKQLDP K674-ub
CAPN2 (rat) VRLEILFKIFKQLDP K674